|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,827.00 GBX | +1.98% |
|
+2.21% | +4.90% |
| 05-19 | Sadif Downgrades Croda International to Strong Sell | MT |
| 04-29 | WINNERS & LOSERS: Pharma in the red; DCC jumps after takeover approach | AN |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 8.69 | 8.09 | 4.4 | 4.09 | 2.1 | |||||
Return on Total Capital | 10.55 | 9.72 | 5.16 | 4.77 | 2.47 | |||||
Return On Equity % | 19.21 | 31.13 | 7.17 | 6.84 | 2.88 | |||||
Return on Common Equity | 19.23 | 31.16 | 7.17 | 6.84 | 2.77 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 49.69 | 47.17 | 43.08 | 45.08 | 43.88 | |||||
SG&A Margin | 26.43 | 25.77 | 28.16 | 30.83 | 37.04 | |||||
EBITDA Margin % | 28.41 | 26.34 | 21.25 | 21.34 | 13.8 | |||||
EBITA Margin % | 25.07 | 23.06 | 17.13 | 16.59 | 9.01 | |||||
EBIT Margin % | 23.25 | 21.4 | 14.92 | 14.24 | 6.84 | |||||
Income From Continuing Operations Margin % | 17.08 | 31.27 | 10.16 | 9.8 | 3.81 | |||||
Net Income Margin % | 16.98 | 31.08 | 10.09 | 9.74 | 3.65 | |||||
Net Avail. For Common Margin % | 16.98 | 31.08 | 10.09 | 9.74 | 3.65 | |||||
Normalized Net Income Margin | 13.66 | 12.54 | 8.65 | 7.91 | 3.19 | |||||
Levered Free Cash Flow Margin | 9.5 | 5.69 | 5.58 | 7.53 | 3.88 | |||||
Unlevered Free Cash Flow Margin | 10.23 | 6.42 | 6.54 | 8.72 | 4.92 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.6 | 0.61 | 0.47 | 0.46 | 0.49 | |||||
Fixed Assets Turnover | 1.84 | 1.95 | 1.55 | 1.42 | 1.53 | |||||
Receivables Turnover (Average Receivables) | 7.33 | 7.06 | 5.36 | 5.47 | 5.94 | |||||
Inventory Turnover (Average Inventory) | 2.55 | 2.43 | 2.4 | 2.52 | 2.58 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.94 | 2.38 | 2.84 | 2.63 | 1.99 | |||||
Quick Ratio | 0.95 | 1.4 | 1.74 | 1.49 | 1.15 | |||||
Operating Cash Flow to Current Liabilities | 0.76 | 0.63 | 1.05 | 0.95 | 0.63 | |||||
Days Sales Outstanding (Average Receivables) | 49.83 | 51.71 | 68.13 | 66.87 | 61.46 | |||||
Days Outstanding Inventory (Average Inventory) | 143.13 | 149.97 | 152.36 | 145.12 | 141.3 | |||||
Average Days Payable Outstanding | 38.64 | 41.23 | 53.49 | 50.18 | 49.01 | |||||
Cash Conversion Cycle (Average Days) | 154.32 | 160.45 | 167 | 161.81 | 153.75 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 53 | 25.33 | 29.99 | 30.44 | 31.63 | |||||
Total Debt / Total Capital | 34.64 | 20.21 | 23.07 | 23.33 | 24.03 | |||||
LT Debt/Equity | 49.43 | 19.79 | 27.86 | 28.34 | 24.25 | |||||
Long-Term Debt / Total Capital | 32.31 | 15.79 | 21.43 | 21.73 | 18.42 | |||||
Total Liabilities / Total Assets | 46.38 | 32.69 | 33.84 | 34.55 | 35.44 | |||||
EBIT / Interest Expense | 19.88 | 18.55 | 9.73 | 7.48 | 4.11 | |||||
EBITDA / Interest Expense | 24.89 | 23.45 | 14.44 | 11.73 | 8.78 | |||||
(EBITDA - Capex) / Interest Expense | 17.96 | 17.59 | 7.5 | 5.97 | 4.63 | |||||
Total Debt / EBITDA | 1.7 | 1.09 | 1.89 | 1.92 | 2.8 | |||||
Net Debt / EBITDA | 1.5 | 0.52 | 1.43 | 1.46 | 2.11 | |||||
Total Debt / (EBITDA - Capex) | 2.36 | 1.45 | 3.64 | 3.77 | 5.32 | |||||
Net Debt / (EBITDA - Capex) | 2.07 | 0.7 | 2.76 | 2.87 | 4 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 35.91 | 10.57 | -18.9 | -3.92 | 4.38 | |||||
Gross Profit, 1 Yr. Growth % | 48.54 | 4.97 | -25.93 | 0.53 | 1.61 | |||||
EBITDA, 1 Yr. Growth % | 45.2 | 2.8 | -34.58 | -3.5 | -32.5 | |||||
EBITA, 1 Yr. Growth % | 50.76 | 2.01 | -39.73 | -6.96 | -43.32 | |||||
EBIT, 1 Yr. Growth % | 46.22 | 2.1 | -43.44 | -8.3 | -49.85 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 60.12 | 102.39 | -73.66 | -7.26 | -59.46 | |||||
Net Income, 1 Yr. Growth % | 59.13 | 102.4 | -73.66 | -7.31 | -60.88 | |||||
Normalized Net Income, 1 Yr. Growth % | 46.13 | 1.87 | -44.06 | -12.15 | -57.93 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 48.26 | 102.53 | -73.69 | -7.2 | -60.88 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.31 | 13.41 | 1.08 | -12.92 | 6.68 | |||||
Inventory, 1 Yr. Growth % | 46.4 | 4.74 | -26.47 | 7.83 | 0.71 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 9.7 | -1.36 | 6.6 | 3.22 | -10.17 | |||||
Total Assets, 1 Yr. Growth % | 8.73 | 9.67 | -0.91 | -1.95 | -2.8 | |||||
Tangible Book Value, 1 Yr. Growth % | 75.97 | 141.96 | -18.79 | 2.96 | -7.1 | |||||
Common Equity, 1 Yr. Growth % | 10.56 | 37.88 | -2.61 | -2.98 | -4.18 | |||||
Cash From Operations, 1 Yr. Growth % | 21.15 | -11.36 | 9.51 | -5.36 | -10.3 | |||||
Capital Expenditures, 1 Yr. Growth % | 33.04 | -7.71 | 27.76 | -1.11 | -34.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 62.79 | -33.38 | -20.56 | 29.68 | -46.23 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 58.84 | -30.33 | -17.36 | 28.15 | -41.11 | |||||
Dividend Per Share, 1 Yr. Growth % | 9.89 | 8 | 0.93 | 0.92 | 0.91 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 17.11 | 22.59 | -5.3 | -11.72 | 0.14 | |||||
Gross Profit, 2 Yr. CAGR % | 21.96 | 24.87 | -11.82 | -13.71 | 1.07 | |||||
EBITDA, 2 Yr. CAGR % | 19.55 | 22 | -17.99 | -20.55 | -19.29 | |||||
EBITA, 2 Yr. CAGR % | 20.03 | 23.82 | -21.59 | -25.12 | -27.38 | |||||
EBIT, 2 Yr. CAGR % | 17.2 | 21.98 | -24 | -27.98 | -32.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 20.1 | 80.02 | -26.98 | -50.57 | -38.69 | |||||
Net Income, 2 Yr. CAGR % | 19.7 | 79.46 | -26.99 | -50.59 | -39.79 | |||||
Normalized Net Income, 2 Yr. CAGR % | 16.81 | 21.79 | -24.51 | -29.9 | -39.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 15.38 | 73.28 | -27 | -50.58 | -39.75 | |||||
Accounts Receivable, 2 Yr. CAGR % | 25.58 | 14.85 | 7.07 | -6.18 | -3.62 | |||||
Inventory, 2 Yr. CAGR % | 28.35 | 23.83 | -12.24 | -10.96 | 4.21 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 12.42 | 4.02 | 2.55 | 4.9 | -3.71 | |||||
Total Assets, 2 Yr. CAGR % | 31.97 | 9.2 | 4.25 | -1.43 | -2.38 | |||||
Tangible Book Value, 2 Yr. CAGR % | 7.57 | 106.35 | 40.18 | -8.56 | -2.2 | |||||
Common Equity, 2 Yr. CAGR % | 42.69 | 23.46 | 15.88 | -2.79 | -3.58 | |||||
Cash From Operations, 2 Yr. CAGR % | 6.96 | 3.63 | -1.48 | 1.8 | -7.86 | |||||
Capital Expenditures, 2 Yr. CAGR % | 20.6 | 10.81 | 8.59 | 12.4 | -19.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 9.19 | 3.87 | -27.25 | 1.5 | -16.5 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 9.26 | 4.94 | -24.12 | 2.9 | -13.13 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.41 | 8.94 | 4.4 | 0.92 | 0.91 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 10.86 | 14.89 | 6.82 | -4.84 | -6.65 | |||||
Gross Profit, 3 Yr. CAGR % | 21.59 | 16.01 | 4.92 | -7.88 | -8.88 | |||||
EBITDA, 3 Yr. CAGR % | 11.69 | 13.58 | -0.88 | -13.42 | -24.75 | |||||
EBITA, 3 Yr. CAGR % | 12 | 13.57 | -2.6 | -16.99 | -31.76 | |||||
EBIT, 3 Yr. CAGR % | 9.91 | 11.81 | -5.59 | -19.1 | -36.17 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 10.65 | 42.92 | -5.14 | -20.93 | -53.73 | |||||
Net Income, 3 Yr. CAGR % | 10.39 | 42.6 | -5.34 | -20.94 | -54.29 | |||||
Normalized Net Income, 3 Yr. CAGR % | 8.79 | 11.47 | -6.04 | -20.6 | -40.87 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 7.49 | 39.18 | -7.55 | -20.92 | -54.29 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.51 | 21.38 | 10.06 | -0.06 | -2.08 | |||||
Inventory, 3 Yr. CAGR % | 15.54 | 19.94 | 4.08 | -6 | -7.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 11.31 | 7.63 | 4.88 | 2.77 | -0.39 | |||||
Total Assets, 3 Yr. CAGR % | 19.86 | 24.07 | 5.72 | 2.14 | -1.89 | |||||
Tangible Book Value, 3 Yr. CAGR % | -3.49 | 40.94 | 51.22 | 26.48 | -8.08 | |||||
Common Equity, 3 Yr. CAGR % | 20.98 | 41.07 | 14.08 | 9.22 | -3.26 | |||||
Cash From Operations, 3 Yr. CAGR % | 9.89 | 0.47 | 5.55 | -2.79 | -2.4 | |||||
Capital Expenditures, 3 Yr. CAGR % | 15.15 | 10.31 | 16.19 | 5.25 | -5.89 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 22.72 | -7.55 | -5.01 | -11.79 | -17.87 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 22.83 | -6.11 | -3.09 | -9.64 | -14.56 | |||||
Dividend Per Share, 3 Yr. CAGR % | 3.91 | 6.27 | 6.2 | 3.23 | 0.92 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 8.73 | 8.76 | 4.09 | 3.4 | 4.1 | |||||
Gross Profit, 5 Yr. CAGR % | 16.1 | 13.76 | 6.93 | 3.06 | 3.36 | |||||
EBITDA, 5 Yr. CAGR % | 10.2 | 7.98 | -1.35 | -1.55 | -8.7 | |||||
EBITA, 5 Yr. CAGR % | 10.6 | 8.06 | -2.95 | -3.86 | -13.39 | |||||
EBIT, 5 Yr. CAGR % | 9.19 | 6.71 | -5.23 | -6.23 | -17.29 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.31 | 22.51 | -6.3 | -6.54 | -20.33 | |||||
Net Income, 5 Yr. CAGR % | 10.28 | 22.33 | -6.44 | -6.68 | -21.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 8.54 | 5.86 | -6.07 | -7.41 | -21.06 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.81 | 20.44 | -7.92 | -8.02 | -22.1 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.59 | 13.03 | 10.3 | 9.5 | 4.37 | |||||
Inventory, 5 Yr. CAGR % | 13.45 | 12.41 | 3.51 | 6.47 | 4.13 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.46 | 9.19 | 7.72 | 6.53 | 1.35 | |||||
Total Assets, 5 Yr. CAGR % | 17.04 | 16.98 | 13.35 | 13.16 | 2.4 | |||||
Tangible Book Value, 5 Yr. CAGR % | 14.49 | 21.73 | 12.05 | 18.54 | 27.03 | |||||
Common Equity, 5 Yr. CAGR % | 23.92 | 24.08 | 18.91 | 21.54 | 6.66 | |||||
Cash From Operations, 5 Yr. CAGR % | 5.68 | 3.26 | 5.19 | 1 | -0.03 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.07 | -1.95 | 12.48 | 11.14 | 0.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 9.17 | 6.7 | -0.54 | -4.03 | -9.78 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.85 | 7.91 | 1.21 | -2.6 | -7.24 | |||||
Dividend Per Share, 5 Yr. CAGR % | 5.7 | 5.41 | 4.11 | 4.1 | 4.05 |
- Stock Market
- Equities
- CRDA Stock
- Financials Croda International Plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















